TY  - GEN
AU  - Davé,Shaival H
AU  - Tilstra,Jeremy S
AU  - Matsuoka,Katsuyoshi
AU  - Li,Fengling
AU  - DeMarco,Richard A
AU  - Beer-Stolz,Donna
AU  - Sepulveda,Antonia R
AU  - Fink,Mitchell P
AU  - Lotze,Michael T
AU  - Plevy,Scott E
TI  - Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis
SN  - 1938-3673
PY  - 2009///1014
KW  - Adenocarcinoma
KW  - metabolism
KW  - Animals
KW  - Annexin A5
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Colitis
KW  - chemically induced
KW  - Colonic Neoplasms
KW  - Cytokines
KW  - antagonists & inhibitors
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorescein-5-isothiocyanate
KW  - HMGB1 Protein
KW  - In Situ Nick-End Labeling
KW  - Interleukin-10
KW  - deficiency
KW  - Interleukin-12 Subunit p40
KW  - Intestinal Mucosa
KW  - Liver Neoplasms
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Microtubule-Associated Proteins
KW  - Neoplasm Metastasis
KW  - Neoplasm Transplantation
KW  - Nitric Oxide
KW  - Poly (ADP-Ribose) Polymerase-1
KW  - Poly(ADP-ribose) Polymerases
KW  - Pyruvates
KW  - Random Allocation
KW  - Receptor for Advanced Glycation End Products
KW  - Receptors, Immunologic
KW  - Transfection
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1189/jlb.1008662
ER  -